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Hepatocyte growth factor as a renotrophic factor: Significance
in kidney disease
T Nakamura
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Hepatocyte growth factor (HGF) has been discovered, purified,
and molecularly cloned as a potent mitogen for mature hepato-
cytes. HGF is thought to be a hepatotropic factor which acts as a
trigger for liver regeneration after injury. HGF is a heterodimeric
molecule composed of a 69 kD cr-chain and a 34 kD n-chain which
is linked by a disulfide bridge. Four kringle domains are located
on the cr-chain.
HGF is produced by mesenchymal cells and acts on a wide
variety of epithelial cells. It can function as a mitogen (stimulating
cell growth), motogen (stimulating cell motility), morphogen
(inducing multicellular tissue structure) and tumor suppressor
(suppressing cell growth). These pleiotropic functions of HGF are
essential biological activities for the construction of normal tissue
architecture. Thus, HGF may be one of the long-sought humoral
mediators of morphogenic epithelial-mesenchymal interactions
which are essential for organogenesis. The HGF-receptor has
been identified as the product of the c-met proto-oncogene. This
receptor is a 195 kD transmembrane protein that possesses
tyrosine kinase activities.
HGF mRNA and HGF activity are rapidly and markedly
increased in the liver after various liver injuries. Intravenous
injection of recombinant HGF into mouse remarkably enhanced
liver regeneration in vivo. Moreover, administration of recombi-
nant HGF prevented the onset and progression of hepatic cirrho-
sis in rats and completely abrogated death caused by severe
hepatic cirrhosis. HGF also exerts mitogenic and morphogenic
activities for renal epithelial cells. HGF mRNA in injured kidney
and blood HGF levels were markedly induced after unilateral
nephrectomy and acute renal failure. Exogenously injected HGF
remarkably enhanced renal regeneration in vivo. Intravenous
injection of recombinant HGF into rats with acute renal injury
markedly prevented the onset of severe renal dysfunction and
enhanced the regeneration of the injured kidney. These findings
suggest that HGF, a hepatotrophic factor, also functions as a
renotrophic factor required for renal regeneration. This factor
may be used for effective 'growth factor therapy' in patients with
hepatic and renal dysfunction.
References
1. MATSUMOTO K, NAKAMURA T: Hepatocyte growth factor: Molecular
structure, roles in liver regeneration, and other biological functions.
Grit Rev Oncogen 3:27—54, 1992
2. ISHIKI Y, OHNIsHI H, MUTO Y, MATSUMOTO K, NAKAMURA T: Direct
evidence that hepatocyte growth factor is a hepatotrophic factor for
liver regeneration and has a potent anti-hepatitis effect in vivo. Hepa-
tology 16:1227—1235, 1992
Institute de Recherches Cliniques de Montreal, Montreal, Canada and
Columbia University, New York; New York; USA
Among renal cystic disorders, polycystic kidney disease (PKD)
is considered to be the most prevalent and clinically important
inherited disease. The etiology and pathogenesis of PKD still
remain to be defined. Three mechanisms of cystogenesis have
been proposed to cause tubular epithelial cysts: increased tubular
epithelial proliferation, alteration in tubular basement membrane,
and mislocation of the Na/K ATPase pump, resulting in abnor-
malities of ion and fluid secretion.
Recently, several investigators have focused their attention on
hereditary models of PKD which resemble the human disorder.
These include spontaneously occurring and targeted genetic mod-
els of PKD established by transgenic or insertional mutagenesis
techniques. Transgenic mice with a PKD phenotype have been
produced using oncogenes known to be involved in cell prolifer-
ation. Transgenic mice generated with the SV4O early region
develop cysts and glomerulosclerosis associated with proteinuria.
These mice also display renal tubular epithelial hyperplasia,
thymic hyperplasia and lethal choroid plexus tumors. We have
produced a transgenic mouse model of PKD known as SBM. The
transgene consists of the SV40 enhancer, the adult human 13-gb-
bin promoter and the coding region of the c-myc oncogene.
Nineteen transgenic founder mice have been generated.
All SBM founders and mice derived from these founder lines
develop a characteristic PKD phenotype with complete pen-
etrance leading to death from renal failure at six weeks to three
months of age. Histopathologic studies from gestational age to
adulthood have elucidated the evolution of the cystic phenotype.
Renal and glomerular cysts are first detectable in the terminal
stages of renal organogenesis in SBM fetuses. From a young age
(1 to 20 days), transgenic SBM mice develop progressively in-
creasing cyst number and size. In addition, these young SBM mice
have severe epithelial hyperplasia primarily in the proximal
tubules. Fifty percent of young SBM mice develop one or more
microadenomas. Hyperplasia also affected the visceral and pan-
etal epithelium of some glomeruli leading to formation of cres-
cents. Thus, hyperplasia was noted in three related renal epithe-
hum cell types, the proximal tubular, parietal and visceral
epithelium, all of which are derived embryologically from the
proximal metanephric epithelium. In adult SBM mice, the cystic
changes were very severe. Presence of proteinaceous cysts and
interstitial fibrosis were consistently associated with the mature
phenotype. Segmentally or globally sclerotic glomeruli were fre-
quently observed in the kidneys of adult mice but were not a
feature of fetal and young SBM kidneys. Hence, it is likely that
glomerulosclerosis occurs secondary to tubular cysts. These re-
sults suggests that glomeruloscelerosis may arise from at least two
Role of proto-oncogenes in cell proliferation
M. Trudel, V. D'Agati
